Results 101 to 110 of about 75,694 (255)

Crimean-congo hemorrhagic fever: Case series from a medical center in golestan province, Northeast of Iran (2004-2006) [PDF]

, 2006
Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed lethal disease, worldwide. Humans are usually infected with CCHF virus through a tick bite or close contact with viral contaminated tissues or with blood of domestic animals or of infected ...
Abbasi, A., Besharat, S., Jabbari, A., Kalavi, K., Moradi, A.   +4 more
core  

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis [PDF]

, 2016
UNLABELLED: Prisoners have a high prevalence of hepatitis C virus (HCV), but case-finding may not have been cost-effective because treatment often exceeded average prison stay combined with a lack of continuity of care. We assessed the cost-effectiveness
Brew, Iain F., Hickman, Mathew, Hutchinson, Sharon J., Irving, William L., Mandal, Sema, Martin, Natasha K., Miners, Alec, O'Moore, Eamonn, Saksena, Sushma, Vickerman, Peter, Williamson, Joan   +10 more
core   +2 more sources

Therapeutic Effects of Ribavirin Given by the Intraperitoneal or Aerosol Route Against Influenza Virus Infections in Mice [PDF]

, 1976
E. L. Stephen, Joseph W. Dominik, J. B. Moe, J. S. Walker   +3 more
openalex   +1 more source

Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study [PDF]

, 2010
Background and study aims : Large international clinical trials conducted in the past 5 years rapidly improved the treatment of chronic hepatitis C; however, it is unclear whether the advances seen in clinical trials are being paralleled by similar ...
Adler, M, Bastens, B, Brasseur, JP, Colle, Isabelle, Delwaide, J, Denys, AM, Golstein, P, Henrion, J, Horsmans, Y, Michielsen, P, Mulkays, JP, Nevens, F, Van Steenbergen, W, Van Vlierberghe, Hans, Yap, P   +14 more
core   +2 more sources

EFFECT OF RIBAVIRIN ON VIRAL HEPATITIS IN LABORATORY ANIMALS [PDF]

, 1977
Robert W. Sidwell, John H. Huffman, Nancy Campbell, Lois B. Allen   +3 more
openalex   +1 more source

Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial

Annals of Hepatology, 2003
Treatment with polyethylene glycol-modified interferon alfa-2a (peginterferon) alone produces significantly higher sustained antiviral responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.
Francisco Bosques-Padilla, MD, Rafael Trejo-Estrada, MD, Octaivio Campollo-Rivas, MD, Carlos Cortez-HernÁndez, MD, Margarita Dehesa-Violante, MD, Héctor Maldonado-Garza, MD, Raúl Pérez-Gómez, MD, Armando Cabrera-Valdespino, MD   +7 more
doaj  

EFFECT OF RIBAVIRIN ON VIRAL TRANSCRIPTION [PDF]

, 1987
Philip Toltzis, Holly Glover, Kevin O’Connell, Jean L. Patterson   +3 more
openalex   +1 more source

Effect of Ribavirin and immune serum on Junin virus-infected primates [PDF]

, 1986
Mercedes Weissenbacher, María Mercedes Ávila, Miguel A. Calello, M. S. Merani, Joseph B. McCormick, Marı́a Eugenia Rodrı́guez   +5 more
openalex   +1 more source

Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin

Journal of the Formosan Medical Association, 2020
Background/Purpose: The major dose-limiting toxicity of ribavirin is hemolytic anemia. We investigated the incidence, risk factors and impact on virological response of anemia in chronic hepatitis C genotype 2 patients receiving sofosbuvir plus ribavirin
Chi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, Chien-Heng Shen, Te-Sheng Chang, Wei-Ming Chen, Huang-Wei Xu, Chih-Wei Yen, Yi-Hsing Chen, Sheng-Nan Lu, Chao-Hung Hung   +10 more
doaj  

Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy

BMC Infectious Diseases
Background Globally, 80 million people are suffering from chronic Hepatitis C virus (HCV) infection. Sofosbuvir ribavirin-based anti-HCV therapy is associated with anemia and other adverse effects.
Sameen Amjed, Hafiz Ghulam Murtaza Saleem, Sajjad Ullah, Shahzad Latif, Shabana, Junaid Jafar, Ahmad Bilal Waqar   +6 more
doaj   +1 more source